A study also suggested that immune-related pathways, including TNFA signaling via NFKB, IFN-α response, and IFN-γ response, are enriched in glioma and highly correlated with tumor progression [47], which is strong supporting evidence for our results. This evidence concerns the gene NFKB1 and central nervous system cancer.